- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
October 31st, 2006
Nanogen, Inc. (Nasdaq:NGEN), developer of advanced diagnostic products, announced today that
Heiner Dreismann, Ph.D. has been named to its Board of Directors.
Dreismann, currently CEO of FasTraQ, Inc., has more than 20 years
experience with Roche in the biotech and healthcare industry, most recently
as president and CEO of Roche Molecular Systems.
|Related News Press|
Nanoparticle therapy that uses LDL and fish oil kills liver cancer cells February 9th, 2016
A fast solidification process makes material crackle February 8th, 2016
From allergens to anodes: Pollen derived battery electrodes February 8th, 2016
Semblant Appoints Donald Cunningham as Chief Commercial Officer January 2nd, 2016